SeaStar Medical to Report First Quarter Financial Results on May 14, 2025
SeaStar Medical (Nasdaq: ICU) has announced it will release its first quarter 2025 financial results after market close on Wednesday, May 14, 2025. The company, which specializes in treatments for critically ill patients facing organ failure, will host a conference call and webcast at 4:30 p.m. ET / 2:30 p.m. MT on the same day to discuss the results and business progress.
Interested parties can access the call using Conference ID 2078693, with dial-in numbers 1 (800) 715-9871 for U.S. participants and 1 (646) 307-1963 for international callers. A replay will be available through May 20, 2025, at 1 (609) 800-9909.
SeaStar Medical (Nasdaq: ICU) ha annunciato che pubblicherà i risultati finanziari del primo trimestre 2025 dopo la chiusura del mercato di mercoledì 14 maggio 2025. L'azienda, specializzata in trattamenti per pazienti critici affetti da insufficienza d'organo, terrà una conference call e una webcast alle 16:30 ET / 14:30 MT dello stesso giorno per discutere i risultati e i progressi aziendali.
Gli interessati potranno partecipare alla chiamata utilizzando il Conference ID 2078693, con i numeri di accesso 1 (800) 715-9871 per i partecipanti dagli Stati Uniti e 1 (646) 307-1963 per chiamate internazionali. Una registrazione sarà disponibile fino al 20 maggio 2025 al numero 1 (609) 800-9909.
SeaStar Medical (Nasdaq: ICU) ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 después del cierre del mercado el miércoles 14 de mayo de 2025. La compañía, especializada en tratamientos para pacientes críticos con insuficiencia orgánica, realizará una llamada conferencia y una transmisión en vivo a las 4:30 p.m. ET / 2:30 p.m. MT del mismo día para discutir los resultados y el progreso empresarial.
Los interesados pueden acceder a la llamada utilizando el ID de conferencia 2078693, con los números de marcación 1 (800) 715-9871 para participantes en EE. UU. y 1 (646) 307-1963 para llamadas internacionales. Una repetición estará disponible hasta el 20 de mayo de 2025 en el número 1 (609) 800-9909.
SeaStar Medical (나스닥: ICU)는 2025년 5월 14일 수요일 장 마감 후 2025년 1분기 재무실적을 발표할 예정입니다. 장기 부전으로 고통받는 중환자 치료를 전문으로 하는 이 회사는 같은 날 오후 4시 30분 ET / 오후 2시 30분 MT에 컨퍼런스 콜과 웹캐스트를 개최하여 실적과 사업 진행 상황을 논의할 예정입니다.
관심 있는 분들은 컨퍼런스 ID 2078693을 사용하여 전화에 참여할 수 있으며, 미국 참가자는 1 (800) 715-9871, 국제 전화는 1 (646) 307-1963으로 전화할 수 있습니다. 녹음된 방송은 2025년 5월 20일까지 1 (609) 800-9909에서 다시 들을 수 있습니다.
SeaStar Medical (Nasdaq : ICU) a annoncé qu'elle publiera ses résultats financiers du premier trimestre 2025 après la clôture du marché, le mercredi 14 mai 2025. L'entreprise, spécialisée dans les traitements pour les patients en état critique souffrant d'insuffisance organique, organisera une conférence téléphonique et une webdiffusion à 16h30 ET / 14h30 MT le même jour pour discuter des résultats et des progrès commerciaux.
Les personnes intéressées peuvent accéder à l'appel en utilisant l'ID de conférence 2078693, avec les numéros d'appel 1 (800) 715-9871 pour les participants américains et 1 (646) 307-1963 pour les appels internationaux. Une rediffusion sera disponible jusqu'au 20 mai 2025 au 1 (609) 800-9909.
SeaStar Medical (Nasdaq: ICU) hat angekündigt, seine Finanzergebnisse für das erste Quartal 2025 nach Börsenschluss am Mittwoch, den 14. Mai 2025, zu veröffentlichen. Das Unternehmen, das sich auf Behandlungen für kritisch kranke Patienten mit Organversagen spezialisiert hat, wird am selben Tag um 16:30 Uhr ET / 14:30 Uhr MT eine Telefonkonferenz und Webcast abhalten, um die Ergebnisse und den Geschäftsf Fortschritt zu besprechen.
Interessierte können über die Konferenz-ID 2078693 an dem Anruf teilnehmen, mit den Einwahlnummern 1 (800) 715-9871 für US-Teilnehmer und 1 (646) 307-1963 für internationale Anrufer. Eine Aufzeichnung ist bis zum 20. Mai 2025 unter der Nummer 1 (609) 800-9909 verfügbar.
- None.
- None.
DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 14, 2025, and host a webcast and conference call to discuss its financial results and business progress.
| Date/Time: | Wednesday, May 14, 2025, at 4:30 p.m. ET / 2:30 p.m. MT |
| Webcast: | The live webcast and replay can be found here. |
| Conference ID: | 2078693 |
| Dial-in numbers: | 1 (800) 715-9871 within the U.S. |
| 1 (646) 307-1963 from outside the U.S. | |
A replay of the call will be available after 7:30 pm ET and can be accessed as follows:
- The webcast replay is available here.
- The call replay number is 1 (609) 800-9909 and will be available through May 20, 2025.
About SeaStar Medical
SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. SeaStar’s first commercial product, QUELIMMUNE (SCD-PED), was approved in 2024 by the U.S. Food and Drug Administration (FDA). It is the only FDA approved product for the ultra-rare condition of life-threatening acute kidney injury (AKI) due to sepsis or a septic condition in critically ill pediatric patients. SeaStar’s Selective Cytopheretic Device (SCD) therapy has been awarded Breakthrough Device Designation for six therapeutic indications by the FDA, enabling the potential for a speedier pathway to approval and preferable reimbursement dynamics at commercial launch. The company is currently conducting a pivotal trial of its SCD therapy in adult patients with AKI requiring continuous renal replacement therapy, a life-threatening condition with no effective treatment options that impacts over 200,000 adults in the U.S. annually.
For more information visit www.seastarmedical.com or visit us on LinkedIn or X.
Contact:
SeaStar Investor Relations:
IR@SeaStarMed.com
FAQ
When will SeaStar Medical (ICU) report Q1 2025 earnings?
How can I join SeaStar Medical's Q1 2025 earnings call?
Until when is SeaStar Medical's Q1 2025 earnings call replay available?
What time is SeaStar Medical's Q1 2025 earnings call?
